Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Stewart

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Before we throw out progression-free survival as a valid end pointDavid J Stewart
The Oncologist|December 24, 2004
Foreword--new directions for topotecan in lung cancer treatmentDavid J Stewart
Critical Reviews in Oncology/Hematology|January 6, 2010
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerDavid J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Gefitinib maintenance in stage III non-small-cell lung cancerDavid J Stewart
Oncotarget|January 7, 2016
Click chemistry, 3D-printing, and omics: the future of drug developmentRazelle Kurzrock, David J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Cancer: the road to AmiensDavid J Stewart, Razelle Kurzrock
BMC Cancer|April 17, 2013
Fool's gold, lost treasures, and the randomized clinical trialDavid J Stewart, Razelle Kurzrock
Oncology (Williston Park, N.Y.)|April 16, 2008
Systemic therapy for lung cancer brain metastases: a rationale for clinical trialsYun Oh, David J Stewart
The Oncologist|March 5, 2013
Compliance in early-phase cancer clinical trials researchRazelle Kurzrock, David J Stewart
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2016
Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer PatientsRazelle Kurzrock, David J Stewart
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Before we throw out progression-free survival as a valid end pointDavid J Stewart
The Oncologist|December 24, 2004
Foreword--new directions for topotecan in lung cancer treatmentDavid J Stewart
Critical Reviews in Oncology/Hematology|January 6, 2010
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerDavid J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Gefitinib maintenance in stage III non-small-cell lung cancerDavid J Stewart
Oncotarget|January 7, 2016
Click chemistry, 3D-printing, and omics: the future of drug developmentRazelle Kurzrock, David J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Cancer: the road to AmiensDavid J Stewart, Razelle Kurzrock
BMC Cancer|April 17, 2013
Fool's gold, lost treasures, and the randomized clinical trialDavid J Stewart, Razelle Kurzrock
Oncology (Williston Park, N.Y.)|April 16, 2008
Systemic therapy for lung cancer brain metastases: a rationale for clinical trialsYun Oh, David J Stewart
The Oncologist|March 5, 2013
Compliance in early-phase cancer clinical trials researchRazelle Kurzrock, David J Stewart
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2016
Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer PatientsRazelle Kurzrock, David J Stewart
Pageof 16